The DOI matches its Crossref record; 59 of the 59 references it cites were found in a registry or an index.
Psychotropic drug prescriptions in Western European nursing homes
Open accessAbstract
BACKGROUND: Despite the numerous warnings of European and national drug agencies as well as clinical guidelines since the year 2004, psychotropic drugs are still frequently used in dementia. A systematic review comparing the use of psychotropic drugs in nursing homes from different European countries is lacking. OBJECTIVE: The aim of this study was to examine prescription rates of psychotropic drug use in nursing home patients between different Western European countries since the first warnings were published. METHODS: A literature review was performed and the various psychotropic prescribing rates in European nursing homes were investigated. The prescription rates of antipsychotic and antidepressants were pooled per country. Other classes of psychotropic drugs could not be pooled because of the limited number of studies found. RESULTS: Thirty-seven studies on antipsychotic drug use and 27 studies on antidepressant drug use conducted in 12 different European countries. The antipsychotic use in nursing homes ranged from 12% to 59% and antidepressant use from 19% to 68%. The highest rates of antipsychotic drug prescription were found in Austria, Ireland, and Belgium while for antidepressants in Belgium, Sweden, and France. CONCLUSIONS: Despite warnings about the side effects and recommendation to focus on non-pharmacological interventions, antipsychotics and antidepressants are commonly used drugs in nursing homes. The data suggest that Norway does best with regards having a low antipsychotic drug usage. Studies are needed to explain the differences between Norway and other European countries.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Rates of prescribing are particularly high across care homes, where studies in the Western Europe have shown that up to 63% of residents are prescribed at least one psychotropic drug [5–8].”
From Stakeholders' views on the use of psychotropic medication in older people: a systematic review (2022) · cites this paper as [8]
In the citing paper
“Previous research has also shown that country of residence is more important than clinical factors in determining psychotropic use and this also suggests that prescribing habits, social, cultural, behavioural and regulatory factors play an important role [8, 87].”
From Stakeholders' views on the use of psychotropic medication in older people: a systematic review (2022) · cites this paper as [8]
Citations
Cites
Barendregt, J. J., Doi, S. A., Lee, Y. Y., Norman, R. E., & Vos, T. (2013) · Journal of Epidemiology and Community Health · doi:10.1136/jech-2013-203104 · Cited by 2,169
Pharmacological Treatment of Neuropsychiatric Symptoms of Dementia: A Review of the Evidence
Sink, K. M., Holden, K. F., & Yaffe, K. (2005) · JAMA · doi:10.1001/jama.293.5.596 · Cited by 910
Point and 5‐year period prevalence of neuropsychiatric symptoms in dementia: the Cache County Study
Steinberg, M., Shao, H., Zandi, P., Lyketsos, C. G., Welsh‐Bohmer, K. A., Norton, M. C., Breitner, J. C. S., Steffens, D. C., & Tschanz, J. T. (2008) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.1858 · Cited by 780
Potentially Inappropriate Medication Use Among Elderly Home Care Patients in Europe
Fialová, D. (2005) · JAMA · doi:10.1001/jama.293.11.1348 · Cited by 709
Husebo, B. S., Ballard, C., Sandvik, R., Nilsen, O. B., & Aarsland, D. (2011) · BMJ · doi:10.1136/bmj.d4065 · Cited by 571
Meta-Analysis of Nonpharmacological Interventions for Neuropsychiatric Symptoms of Dementia
Brodaty, H., & Arasaratnam, C. (2012) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2012.11101529 · Cited by 479
Management of behavioral problems in Alzheimer's disease
Gauthier, S. G., Cummings, J. L., Ballard, C. G., Brodaty, H., Grossberg, G. T., Robert, P. H., & Lyketsos, C. G. (2010) · International Psychogeriatrics · doi:10.1017/s1041610209991505 · Cited by 379
the SHELTER project, Onder, G., Carpenter, I., Finne‐Soveri, H., Gindin, J., Frijters, D. H. M., Henrard, J. C., Nikolaus, T., Topinková, E., Tosato, M., et al. (2012) · BMC Health Services Research · doi:10.1186/1472-6963-12-5 · Cited by 320
Place of Death of Older Persons with Dementia. A Study in Five European Countries
Houttekier, D., Cohen, J., Bilsen, J. J. R., Addington-Hall, J. M., Onwuteaka-Philipsen, B. D., & Deliëns, L. (2010) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2010.02771.x · Cited by 267
Nursing Home and Nursing Home Physician: The Dutch Experience
Schols, J. M. G. A., Crebolder, H. F. J. M., & van Weel, C. (2004) · Journal of the American Medical Directors Association · doi:10.1016/s1525-8610(04)70116-4 · Cited by 200
Azermai, M., Petrović, M., Elseviers, M. M., Bourgeois, J., Bortel, L. M. V., & Stichele, R. V. (2011) · Ageing Research Reviews · doi:10.1016/j.arr.2011.07.002 · Cited by 197
Course of Neuropsychiatric Symptoms in Residents with Dementia in Nursing Homes Over 2-Year Period
Wetzels, R. B., Zuidema, S. U., de Jonghe, J. F. M., Verhey, F. R. J., & Koopmans, R. T. C. M. (2010) · American Journal of Geriatric Psychiatry · doi:10.1097/jgp.0b013e3181f60fa1 · Cited by 158
Prevalence of dementia in nursing home and community-dwelling older adults in Germany
Hoffmann, F., Kaduszkiewicz, H., Glaeske, G., van den Bussche, H., & Koller, D. (2014) · Aging Clinical and Experimental Research · doi:10.1007/s40520-014-0210-6 · Cited by 147
Zwijsen, S. A., Kabboord, A., Eefsting, J. A., Hertogh, C. M. P. M., Pot, A. M., Gerritsen, D. L., & Smalbrugge, M. (2013) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.4014 · Cited by 145
Ballard, C. G., Creese, B., Corbett, A., & Aarsland, D. (2010) · Expert Opinion on Drug Safety · doi:10.1517/14740338.2010.506711 · Cited by 142
Richter, T., Mann, E., Meyer, G., Haastert, B., & Köpke, S. (2011) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2011.03.007 · Cited by 132
Ballard, C. G., Corbett, A., Chitramohan, R., & Aarsland, D. (2009) · Current Opinion in Psychiatry · doi:10.1097/yco.0b013e32833111f9 · Cited by 116
Kuske, B., Luck, T., Hanns, S., Matschinger, H., Angermeyer, M. C., Behrens, J., & Riedel-Heller, S. G. (2009) · International Psychogeriatrics · doi:10.1017/s1041610208008387 · Cited by 113
A 12 months follow-up study of depression among nursing-home patients in Norway
Barca, M. L., Engedal, K., Laks, J., & Selbaek, G. (2010) · Journal of Affective Disorders · doi:10.1016/j.jad.2009.04.028 · Cited by 104
Gallini, A., Andrieu, S., Donohue, J. M., Oumouhou, N., Lapeyre‐Mestre, M., & Gardette, V. (2013) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2013.09.003 · Cited by 99
Descriptive study of nursing home residents from the REHPA network
Rolland, Y., van Kan, G. A., Hermabessière, S., Gérard, S., Guyonnet, S., & Vellas, B. J. (2009) · The journal of nutrition health & aging · doi:10.1007/s12603-009-0197-4 · Cited by 94
Prescribing pattern of psychotropic drugs in nursing home residents with dementia
Wetzels, R. B., Zuidema, S. U., de Jonghe, J. F. M., Verhey, F. R. J., & Koopmans, R. T. C. M. (2011) · International Psychogeriatrics · doi:10.1017/s1041610211000755 · Cited by 91
Stewart, R. J., Hotopf, M. H., Dewey, M. E., Ballard, C. G., Bisla, J., Calem, M., Fahmy, V., Hockley, J., Kinley, J., Pearce, H., et al. (2014) · Age and Ageing · doi:10.1093/ageing/afu062 · Cited by 83
Benzodiazepine use in Belgian nursing homes: a closer look into indications and dosages
Bourgeois, J., Elseviers, M. M., Azermai, M., Bortel, L. M. V., Petrović, M., & Stichele, R. V. (2011) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-011-1188-z · Cited by 75
Johnell, K., & Fastbom, J. (2012) · Drugs & Aging · doi:10.1007/s40266-012-0002-7 · Cited by 74
Gustafsson, M. V., Karlsson, S., & Lövheim, H. (2013) · BMC Pharmacology and Toxicology · doi:10.1186/2050-6511-14-10 · Cited by 70
Zuidema, S. U., Johansson, A., Selbæk, G., Murray, M., Burns, A. S., Ballard, C. G., & Koopmans, R. T. C. M. (2015) · International Psychogeriatrics · doi:10.1017/s1041610215000745 · Cited by 70
Helvik, A., Engedal, K., Benth, J. Š., & Selbæk, G. (2014) · BMC Geriatrics · doi:10.1186/1471-2318-14-45 · Cited by 69
Potentially Inappropriate Drug Prescribing and Associated Factors in Nursing Homes
Cool, C., Cestac, P., Laborde, C., Lebaudy, C., Rouch, L., Lepage, B., Vellas, B. J., Barreto, P. D. S., Rolland, Y., & Lapeyre‐Mestre, M. (2014) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2014.08.003 · Cited by 66
Estimating the prevalence of dementia: cognitive screening in Glasgow nursing homes
Lithgow, S., Jackson, G. A., & Browne, D. (2011) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.2784 · Cited by 63
The course of neuropsychiatric symptoms in patients with dementia in Norwegian nursing homes
Bergh, S., Engedal, K., Røen, I., & Selbæk, G. (2011) · International Psychogeriatrics · doi:10.1017/s1041610211001177 · Cited by 63
Shah, S. M., Carey, I. M., Harris, T. J., DeWilde, S., & Cook, D. G. (2010) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.2557 · Cited by 60
Psychotropic Medications and Falls in Nursing Homes: A Cross-Sectional Study
Olazarán, J., Valle, D., Rexach, J. A. S., Cano, P., & Múñiz, R. (2012) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2012.10.020 · Cited by 57
Schulze, J., van den Bussche, H., Glaeske, G., Kaduszkiewicz, H., Wiese, B., & Hoffmann, F. (2013) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2013.02.001 · Cited by 56
Foebel, A. D., Liperoti, R., Onder, G., Finne‐Soveri, H., Henrard, J. C., Lukas, A., Denkinger, M. D., Gambassi, G., & Bernabei, R. (2014) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2014.07.012 · Cited by 53
The Pharmacotherapy of Neuropsychiatric Symptoms of Dementia
Majić, T., Pluta, J.-P., Mell, T., Aichberger, M. C., Treusch, Y., Gutzmann, H., Heinz, A., & Rapp, M. A. (2010) · Deutsches Ärzteblatt international · doi:10.3238/arztebl.2010.0320 · Cited by 51
Mjørud, M., Røsvik, J., Rokstad, A. M. M., Kirkevold, M., & Engedal, K. (2014) · PLoS ONE · doi:10.1371/journal.pone.0115248 · Cited by 46
Variability between nursing homes in prevalence of antipsychotic use in patients with dementia
Kleijer, B. C., van Marum, R. J., Frijters, D. H. M., Jansen, P. A. F., Ribbe, M. W., Egberts, T. C. G., & Heerdink, E. R. (2013) · International Psychogeriatrics · doi:10.1017/s1041610213002019 · Cited by 46
Gustafsson, M. V., Sandman, P., Karlsson, S., Gustafson, Y., & Lövheim, H. (2013) · International Psychogeriatrics · doi:10.1017/s1041610213000859 · Cited by 46
Barry, H. E., Parsons, C., Passmore, A. P., & Hughes, C. M. (2014) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.4111 · Cited by 45
Pitkälä, K. H., Juola, A.-L., Hosia‐Randell, H., Teramura-Grönblad, M., Soini, H., Savikko, N. M., & Bell, J. S. (2015) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2015.06.009 · Cited by 45
Testad, I., Auer, S., Mittelman, M. S., Ballard, C. G., Fossey, J., Donabauer, Y., & Aarsland, D. (2009) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.2414 · Cited by 42
Borza, T., Engedal, K., Bergh, S., Barca, M. L., Benth, J. Š., & Selbæk, G. (2014) · Journal of Affective Disorders · doi:10.1016/j.jad.2014.12.053 · Cited by 39
Mauléon, A. D., Sourdet, S., Guiteras, A. R., Guyonnet, S., Leino‐Kilpi, H., Karlsson, S., Bleijlevens, M. H. C., Zabalegui, A., Saks, K., Vellas, B. J., et al. (2014) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2014.06.015 · Cited by 38
Iden, K. R., Engedal, K., Hjörleifsson, S., & Ruths, S. (2013) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000355427 · Cited by 37
Trinh, N.-H., Hoblyn, J., Mohanty, S., & Yaffe, K. (2003) · JAMA · doi:10.1001/jama.289.2.210 · Cited by 37
Eggermont, L. H. P., de Vries, K., & Scherder, E. (2009) · International Psychogeriatrics · doi:10.1017/s1041610209008552 · Cited by 35
Toscani, F., Giulio, P. D., Villani, D., Giunco, F., Brunelli, C., Gentile, S., Finetti, S., Charrier, L., Monti, M., & van der Steen, J. T. (2013) · Journal of Palliative Medicine · doi:10.1089/jpm.2012.0165 · Cited by 33
'HE WAS LIKE A ZOMBIE': OFF-LABEL PRESCRIPTION OF ANTIPSYCHOTIC DRUGS IN DEMENTIA
Harding, R., & Peel, E. (2012) · Medical Law Review · doi:10.1093/medlaw/fws029 · Cited by 28
de Mazières, C. L., Lapeyre‐Mestre, M., Vellas, B. J., Barreto, P. D. S., & Rolland, Y. (2015) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2015.01.092 · Cited by 26
Zuidema, S. U., van Iersel, M. B., Koopmans, R. T. C. M., Verhey, F. R. J., & Rikkert, M. G. M. O. (2006) · PubMed · Cited by 25
Antipsychotic prescribing in nursing homes
McCleery, J. M., & Fox, R. A. (2012) · BMJ · doi:10.1136/bmj.e1093 · Cited by 22
Sturm, H., van Gilst, W. H., Veeger, N. J. G. M., & Haaijer‐Ruskamp, F. M. (2006) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1216 · Cited by 21
A reliable and valid index was developed to measure appropriate psychotropic drug use in dementia
van der Spek, K., Gerritsen, D. L., Smalbrugge, M., Nelissen-Vrancken, M. H. J. M. G., Wetzels, R. B., Smeets, C. H. W., Zuidema, S. U., & Koopmans, R. T. C. M. (2015) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2015.03.012 · Cited by 20
Involvement in Activities and Wandering in Nursing Home Residents With Cognitive Impairment
Volicer, L., van der Steen, J. T., & Frijters, D. H. M. (2012) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0b013e31826d012e · Cited by 18
Depression and use of antidepressants in Swedish nursing homes: a 12-month follow-up study
Midlöv, P., Andersson, M., Östgren, C. J., & Mölstad, S. (2013) · International Psychogeriatrics · doi:10.1017/s1041610213002354 · Cited by 17
(2015) · ASHA Leader · doi:10.1044/leader.ppl.20122015.22 · Cited by 11
(2015) · Comptes Rendus Chimie · doi:10.1016/j.crci.2015.09.007 · Cited by 2
Hundertmark, G. (2014) · Cited by 1
Research works printed but not linked: 2
- Banerjee, 2009, The Use of Antipsychotic Medication for People with Dementia: Time for Action
- 9. last accessed 20 December 2015. · DOI
Cited by
Sorted by citations
Antipsychotics for agitation and psychosis in people with Alzheimer's disease and vascular dementia
Mühlbauer, V., Möhler, R., Dichter, M. N., Zuidema, S. U., Köpke, S., & Luijendijk, H. J. (2021) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013304.pub2 · Cited by 117
Antipsychotic deprescription for older adults in long-term care: the HALT study
Brodaty, H., Aerts, L., Harrison, F., Jessop, T., Cations, M., Chenoweth, L., Shell, A., Popovic, G. C., Heffernan, M., Hilmer, S., et al. (2018) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2018.05.002 · Cited by 104
Van Leeuwen, E., van Driel, M. L., Horowitz, M. A., Kendrick, T., Donald, M., De Sutter, A. I., Robertson, L., & Christiaens, T. (2021) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013495.pub2 · Cited by 90
The economics of patient safety Part III: Long-term care
Bienassis, K. D., Nozal, A. L., & Klazinga, N. S. (2020) · OECD health working papers · doi:10.1787/be07475c-en · Cited by 76
Cioltan, H., Alshehri, S. O., Howe, C. L., Lee, J. K., Fain, M. J., Eng, H. J., Schachter, K., & Mohler, J. M. (2017) · BMC Geriatrics · doi:10.1186/s12877-017-0428-1 · Cited by 83
Metadata
- Authors
- Janus, S. I. M., van Manen, J. G., IJzerman, M. J., & Zuidema, S. U.
- Affiliations
- University of Twente (NL)
- University Medical Center Groningen (NL)
- Corresponding author
- Janus, Sarah I. M.
- Venue
- International Psychogeriatrics
- Publisher
- Elsevier BV
- Published
- 2016-07-29
- Volume
- 28
- Issue
- 11
- Pages
- 1775-1790
- ISSN
- 1041-6102 (ISSN-L)
- 1741-203X
- OpenAlex
- W2491277325
- Cited by
- 110
- References
- 59
- Citations by year
- 2026: 3 · 2025: 9 · 2024: 4 · 2023: 6 · 2022: 23 · 2021: 14 · 2020: 16 · 2019: 19 · 2018: 9 · 2017: 6 · 2016: 1
- FWCI
- 1.18
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- International Psychogeriatrics (publishedVersion)
- PubMed (publishedVersion)
- University of Groningen research database (University of Groningen / Centre for Information Technology) (publishedVersion, cc-by-nc-nd)
- University of Twente Research Information (publishedVersion)
- University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion)
- University of Twente Research Information (submittedVersion)
- Topics
- Health Sciences › Medicine › Geriatrics and Gerontology › Pharmaceutical Practices and Patient Outcomes
- Health Sciences › Medicine › Geriatrics and Gerontology › Geriatric Care and Nursing Homes
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- psychotropic drugs, nursing homes, antipsychotic drugs, antidepressants, dementia, prescription rates, Western Europe, cross-national comparison, non-pharmacological treatment
- MeSH terms
- Potentially Inappropriate Medication List, Cross-Cultural Comparison, Dementia, Europe, Homes for the Aged, Humans, Nursing Homes, Psychotropic Drugs, Inappropriate Prescribing
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
